Preferred Label : Trabectedin;
MeSH definition : A complex structure that includes isoquinolines joined by a cyclic ester; it is a
DNA-binding agent and guanine N2 alkylator derived from the marine tunicate, Ecteinascidia
turbinata. Trabectedin is used for the treatment of advanced soft-tissue SARCOMA,
after failure of ANTHRACYCLINES or IFOSFAMIDE drug therapy.;
MeSH hyponym : ET-743; ET743; ET 743;
MeSH Related Number : 114899-77-3 (Trabectedin);
UNII : ID0YZQ2TCP;
Origin ID : D000077606;
UMLS CUI : C1311070;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
Validated automatic mappings to BTNT
A complex structure that includes isoquinolines joined by a cyclic ester; it is a
DNA-binding agent and guanine N2 alkylator derived from the marine tunicate, Ecteinascidia
turbinata. Trabectedin is used for the treatment of advanced soft-tissue SARCOMA,
after failure of ANTHRACYCLINES or IFOSFAMIDE drug therapy.
http://www.has-sante.fr/portail/jcms/c_2630757/fr/yondelis
2016
false
France
French
adult
Soft Tissue Sarcoma
dioxoles
orphan drug production
sarcoma
tetrahydroisoquinolines
antineoplastic agents, alkylating
infusions, intravenous
trabectedin
treatment outcome
leiomyosarcoma
liposarcoma
evaluation of the transparency committee
Trabectedin
---
https://sante.gouv.fr//fichiers/bo/2014/14-03/ste_20140003_0000_0119.pdf
2014
false
false
false
guidelines for drug use
financial support
sarcoma
trabectedin
case management
Trabectedin
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/yondelis_ct_5252.pdf
http://www.has-sante.fr/portail/jcms/c_657266/yondelis
http://www.has-sante.fr/portail/jcms/c_1638066/fr/yondelis
http://www.has-sante.fr/portail/jcms/c_1638351/fr/yondelis-24072013-avis-ct12733
2013
false
France
French
English
guidelines for drug use
dioxoles
orphan drug production
sarcoma
tetrahydroisoquinolines
antineoplastic agents, alkylating
infusions, intravenous
trabectedin
treatment outcome
leiomyosarcoma
liposarcoma
evaluation of the transparency committee
Trabectedin
---
https://www.ema.europa.eu/medicines/human/EPAR/Yondelis
2012
United Kingdom
English
French
syndication feed
orphan drug production
sarcoma
drug approval
treatment outcome
drug labeling
antineoplastic agents, alkylating
antineoplastic agents, alkylating
dioxoles
dioxoles
tetrahydroisoquinolines
tetrahydroisoquinolines
adult
drug interactions
pregnancy
infusions, intravenous
breast feeding
mutagens
drug evaluation, preclinical
trabectedin
dioxoles
tetrahydroisoquinolines
drug evaluation
package leaflet
summary of product characteristics
Trabectedin
Trabectedin
---
http://www.has-sante.fr/portail/jcms/c_990933/yondelis-trabectedine-alcaloide
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/yondelis_-_ct-7917.pdf
2010
France
French
tetrahydroisoquinolines
dioxoles
antineoplastic agents, alkylating
infusions, intravenous
orphan drug production
trabectedin
antineoplastic combined chemotherapy protocols
ovarian neoplasms
treatment outcome
survival analysis
neoplasm recurrence, local
dioxoles
tetrahydroisoquinolines
evaluation of the transparency committee
guidelines for drug use
Trabectedin
---
http://www.has-sante.fr/portail/jcms/c_964922/yondelis
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/yondelis_-_ct-7917.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/yondelis_ct_7917.pdf
2010
France
French
English
tetrahydroisoquinolines
trabectedin
dioxoles
antineoplastic agents, alkylating
neoplasm recurrence, local
ovarian neoplasms
antineoplastic combined chemotherapy protocols
infusions, intravenous
doxorubicin
treatment outcome
dioxoles
tetrahydroisoquinolines
evaluation of the transparency committee
Trabectedin
---